Chin, L., Devine, B., Baradaran, S., Keyloun, K., Canestaro, W., & Pham, J. (2017). Characterizing the Strength of Evidence in FDA Labels for Pharmacogenomic Biomarker-Guided Medication Use. AMIA Jt Summits Transl Sci Proc.
Citação norma ChicagoChin, Lauren, Beth Devine, Sarah Baradaran, Katelyn Keyloun, William Canestaro, and Jonathan Pham. "Characterizing the Strength of Evidence in FDA Labels for Pharmacogenomic Biomarker-Guided Medication Use." AMIA Jt Summits Transl Sci Proc 2017.
Deismireacht MLAChin, Lauren, et al. "Characterizing the Strength of Evidence in FDA Labels for Pharmacogenomic Biomarker-Guided Medication Use." AMIA Jt Summits Transl Sci Proc 2017.
Rabhadh: D'fhéadfadh nach mbeadh na deismireachtaí seo 100% cruinn i gcónaí.